HR 1295: Tardive Dyskinesia Awareness Week 2026; first full week in May; recognize

This resolution does not change any Georgia law. It formally recognizes the first full week of May 2026 as Tardive Dyskinesia Awareness Week in Georgia. Tardive dyskinesia, or TD, is a condition involving uncontrollable, repetitive movements of the face, torso, or limbs that can develop after prolonged use of antipsychotic medications, which are often prescribed for conditions like bipolar disorder, major depressive disorder, and schizophrenia. The resolution cites statistics suggesting that a large share of people with TD in the United States remain undiagnosed, and it notes that certain groups, including older adults, Black individuals, women, and people with mood disorders or substance use disorders, face higher risk. It encourages awareness, education, and routine screening for people prescribed antipsychotics. The House also directs its Clerk to distribute copies of the resolution to the public and press.

• Designates the first full week of May 2026 as Tardive Dyskinesia Awareness Week in Georgia.
• States the House's support for TD awareness, education, and routine screening for people prescribed antipsychotic medications.
• Directs the Clerk of the House of Representatives to prepare and distribute copies of the resolution to the public and press.
• Creates no new legal requirements, funding, or penalties; it is a symbolic recognition rather than a change to Georgia law.

People prescribed antipsychotic medications for conditions like schizophrenia, bipolar disorder, or major depressive disorder, especially those at higher risk of tardive dyskinesia such as older adults, Black individuals, and women. Healthcare providers who treat these patients are also referenced.

While the resolution carries no legal force, it publicly highlights tardive dyskinesia as an under-diagnosed condition among people taking antipsychotics, potentially encouraging patients and doctors to discuss screening and treatment options during the designated awareness week.

• The resolving clause recognizes the first full week in May as Tardive Dyskinesia Awareness Week 2026 and encourages TD awareness, education, and routine screenings.
• A further resolution directs the Clerk of the House of Representatives to make copies available for distribution to the public and the press.
• The whereas clauses cite the American Psychiatric Association's recommendation for routine TD screening in patients on antipsychotic treatment.
• The whereas clauses note that FDA-approved treatments exist for managing TD symptoms.

1. 2026-02-09House Read and Adopted (Cámara de Representantes)
2. 2026-02-09House First Readers (Cámara de Representantes)
3. 2026-02-09House Hopper (Cámara de Representantes)

• Sharon Cooper (R, HD-045)Patrocinador principal
• Tim Fleming (R, HD-114)
• Miriam Paris (D, HD-142)
• Reynaldo Martinez (R, HD-111)

• tardive dyskinesia
• mental health
• antipsychotic medication
• public health awareness
• medical screening